Trial intelligence / Profile preview

Supersaturation and precipitation of ritonavir in the gastrointestinal tract of healthy volunteers

2016-002700-78Phase 4Completed

Sponsor
KU Leuven
Start
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ritonavir, sponsored by KU Leuven. Primary endpoint: Gastrointestinal behavior of ritonavir. Started Sep 2016; status: completed.

02

Drugs

ritonavir

Beyond the preview

Go deeper on 2016-002700-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002700-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call